Form 4 for IGC IGC Pharma, Inc.
Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-20 · accession 0001185185-21-001878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-27 | 2021-12-20 | IGC | PRINS RICHARD K | Dir | A - Grant | $0.00 | +300.0K | 570.0K | +111% | $0 |
| D | 2021-12-27 | 2021-12-23 | IGC | PRINS RICHARD K | Dir | G - Gift | $0.00 | -40.0K | 530.0K | -7% | $0 |
| DM | 2021-12-27 | 2021-12-20 | IGC | PRINS RICHARD K | Dir | A - Grant | $0.00 | +800.0K | 800.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | A | A | 300,000 | $0.00 | 570,000 | D | — | — | (F1) Restricted shares of common stock subject to vesting over three years starting on March 31, 2022, previously reported on Form 4 Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned. (F2) Corrects ownership amount of all previous Section 16 filings of the Reporting Person since April 19, 2013, which overstated the Reporting Person's ownership by 50,000 shares. |
| 2 | Common | Common Stock | 2021-12-23 | G | D | 40,000 | $0.00 | 530,000 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-12-20 | A | A | 300,000 | $0.00 | 300,000 | D | $0.00 · 2022-03-31 to 2024-04-01 | 300,000 Common Stock | (F1) Restricted shares of common stock subject to vesting over three years starting on March 31, 2022, previously reported on Form 4 Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned. (F2) Corrects ownership amount of all previous Section 16 filings of the Reporting Person since April 19, 2013, which overstated the Reporting Person's ownership by 50,000 shares. |
| 4 | Derivative | Restricted Stock Units | 2021-12-20 | A | A | 500,000 | $0.00 | 800,000 | D | $0.00 · — to — | 500,000 Common Stock | (F3) Restricted shares of common stock subject to vesting according to specific milestones set by the Company's Board of Directors. (F4) Restricted shares of common stock do not have an exercisable or expiration date. The RSUs vest when milestones are achieved. |